|
|
| Strides Pharma Science Limited |
|
Financials-Strides Pharma Science Limited| Sector: Bulk Drugs and Formulations | | BSE:532531 | NSE:STAR | Bloomberg:STR@IN | Reuters:STAR.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE939A01011 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2020(3) |
31-Dec-2019(3) |
% Change |
| Sales of Products/Services |
4210.85 |
3644.70 |
15.53 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
162.29 |
176.20 |
-7.89 |
| Total Income |
4373.14 |
3820.90 |
14.45 |
| Total Expenses |
-4099.50 |
-3665.60 |
11.84 |
| OPBDIT |
8472.64 |
7486.50 |
13.17 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-251.53 |
-3665.60 |
-93.14 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-68.75 |
-18.80 |
265.69 |
| After Tax Profit |
204.89 |
136.50 |
50.10 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Dec-05(12) |
|
31-Dec-04(15) |
|
30-Sep-03(18) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
3310.71 |
100.00 |
2852.07 |
93.38 |
2660.31 |
96.83 |
| Operating Income (OI) |
3310.71 |
100.00 |
3054.12 |
100.00 |
2747.44 |
100.00 |
| OPBDIT |
808.42 |
24.42 |
769.01 |
25.18 |
511.45 |
18.62 |
| OPBDT |
523.14 |
15.80 |
466.40 |
15.27 |
182.65 |
6.65 |
| OPBT |
398.44 |
12.03 |
345.65 |
11.32 |
-4.70 |
-0.17 |
| Non-Operating Income |
88.41 |
2.67 |
50.83 |
1.66 |
12.97 |
0.47 |
| Extraordinary/Prior Period |
-1.73 |
-0.05 |
-26.70 |
-0.87 |
57.40 |
2.09 |
| Tax |
24.03 |
0.73 |
78.19 |
2.56 |
2.50 |
0.09 |
| Profit after tax(PAT) |
461.09 |
13.93 |
291.59 |
9.55 |
63.17 |
2.30 |
| Cash Profit |
585.79 |
17.69 |
412.34 |
13.50 |
250.52 |
9.12 |
| Dividend-Equity |
69.90 |
2.11 |
53.35 |
1.75 |
0.00 |
0.00 |
|
| As on |
31-Dec-05 |
|
31-Dec-04 |
|
30-Sep-03 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
1879.19 |
24.04 |
1416.37 |
26.16 |
1299.13 |
26.20 |
| Net Block |
1260.77 |
16.13 |
922.65 |
17.04 |
925.80 |
18.67 |
| Capital WIP |
446.77 |
5.71 |
274.25 |
5.07 |
13.27 |
0.27 |
| Investments |
2704.61 |
34.59 |
1770.81 |
32.71 |
1244.00 |
25.09 |
| Inventory |
502.78 |
6.43 |
270.29 |
4.99 |
243.56 |
4.91 |
| Receivables |
1206.17 |
15.43 |
1215.72 |
22.46 |
1467.55 |
29.60 |
| Other Current Assets |
1697.06 |
21.71 |
959.56 |
17.73 |
1063.61 |
21.45 |
| Balance Sheet Total(BT) |
7818.16 |
100.00 |
5413.28 |
100.00 |
4957.79 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
349.54 |
4.47 |
337.58 |
6.24 |
306.89 |
6.19 |
| Reserves |
2536.20 |
32.44 |
2043.64 |
37.75 |
1827.99 |
36.87 |
| Total Debt |
3675.73 |
47.02 |
2116.97 |
39.11 |
1842.83 |
37.17 |
| Creditors and Acceptances |
748.48 |
9.57 |
588.75 |
10.88 |
709.28 |
14.31 |
| Other current liab/prov. |
508.21 |
6.50 |
326.34 |
6.03 |
270.80 |
5.46 |
| Balance Sheet Total(BT) |
7818.16 |
100.00 |
5413.28 |
100.00 |
4957.79 |
100.00 |
|
| As on |
31-Dec-05 |
31-Dec-04 |
30-Sep-03 |
| OPBIT/Prod.cap.empl.(%) |
20.05 |
21.14 |
7.99 |
| PBIT/Cap. Employed (%) |
12.60 |
12.73 |
6.63 |
| PAT/Networth (%) |
15.98 |
9.80 |
1.97 |
| Tax/PBT (%) |
4.95 |
21.15 |
3.81 |
| Total Debt/Networth (x) |
1.27 |
0.89 |
0.86 |
| Long Term Debt/Networth (x) |
0.88 |
0.67 |
0.52 |
| PBDIT/Finance Charges (x) |
3.14 |
2.62 |
1.77 |
| Current Ratio (x) |
2.71 |
2.67 |
2.83 |
| RM Inventory (days consumption) |
108.27 |
71.31 |
74.30 |
| FG inventory (days cost of sales) |
6.62 |
6.05 |
13.64 |
| Receivables (days gross sales) |
132.91 |
193.88 |
300.31 |
| Creditors (days cost of sales) |
109.18 |
117.55 |
173.67 |
| Op. curr. assets (days OI) |
320.00 |
296.00 |
431.00 |
|
|
Financials